Aziyo biologics to report fourth quarter and full year 2021 financial results on thursday, march 3, 2022

Silver spring, md., feb. 17, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its fourth quarter and full year 2021 earnings results after market close on thursday, march 3, 2022. management will host a conference call to review the company's financial performance starting at 4:30 p.m. eastern time / 1:30 p.m. pacific time on the same day. the conference call will be concurrently webcast.
AZYO Ratings Summary
AZYO Quant Ranking